Woomera Therapeutics, Inc. is a biopharmaceutical company dedicated to the development of novel immuno-products targeting unique markers for the treatment of cancer. Based on over thirty years of research by Dr. William G. North, co-founder and Professor of Physiology at Dartmouth Medical School, this platform technology is developed through an understanding of the biology of distinctive cancer cell markers investigated by Dr. North in his work. Their goal is to develop immuno-products to target certain cancers that express the vasopressin gene and the associated abnormal vasopressin receptor for the early detection, diagnosis, therapy, and prevention of these cancers. Their current commercialization objectives are to develop novel and proprietary products, to define appropriate commercialization strategies, and to secure the team and funding resources necessary to carry out these objectives
